Application 211033
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CLONAZEPAM | CLONAZEPAM | TABLET, ORALLY DISINTEGRATING;ORAL | 0.125MG | No | No |
| 002 | CLONAZEPAM | CLONAZEPAM | TABLET, ORALLY DISINTEGRATING;ORAL | 0.25MG | No | No |
| 003 | CLONAZEPAM | CLONAZEPAM | TABLET, ORALLY DISINTEGRATING;ORAL | 0.5MG | No | No |
| 004 | CLONAZEPAM | CLONAZEPAM | TABLET, ORALLY DISINTEGRATING;ORAL | 1MG | No | No |
| 005 | CLONAZEPAM | CLONAZEPAM | TABLET, ORALLY DISINTEGRATING;ORAL | 2MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 46708-364 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-365 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-366 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-367 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-368 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Limited | ANDA | Current |
| 62332-364 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-364 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-364 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-364 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-364 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-364 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-365 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-365 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-365 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-365 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-365 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-365 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-366 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-366 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-366 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-366 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-366 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-366 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-367 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-367 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-367 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-367 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-367 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-367 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-368 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-368 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-368 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-368 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-368 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-368 | CLONAZEPAM | CLONAZEPAM | Alembic Pharmaceuticals Inc. | ANDA | Current |